Gene · 4055
Papers3,299
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,299
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation. | Front Immunol | 2022 | 35874778 | PubTator, text mining | PubMed |
| A Barrier to Defend - Models of Pulmonary Barrier to Study Acute Inflammatory Diseases. | Front Immunol | 2022 | 35874776 | PubTator, text mining | PubMed |
| The Hepatoprotective Effect of Leonurine Hydrochloride Against Alcoholic Liver Disease Based on Transcriptomic and Metabolomic Analysis. | Front Nutr | 2022 | 35873419 | PubTator, text mining | PubMed |
| Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking. | Front Pharmacol | 2022 | 35865955 | PubTator, text mining | PubMed |
| TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer. | Oncogene | 2022 | 35864174 | PubTator, text mining | PubMed |
| The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers. | Front Immunol | 2022 | 35860251 | PubTator, text mining | PubMed |
| Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation. | mBio | 2022 | 35856559 | PubTator, text mining | PubMed |
| Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma. | Cell Discov | 2022 | 35853872 | PubTator, text mining | PubMed |
| Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases. | Clin Mol Hepatol | 2022 | 35850495 | PubTator, text mining | PubMed |
| Group 3 innate lymphocytes make a distinct contribution to type 17 immunity in bladder defence. | iScience | 2022 | 35845169 | PubTator, text mining | PubMed |
| Apatinib: A Novel Antiangiogenic Drug in Monotherapy or Combination Immunotherapy for Digestive System Malignancies. | Front Immunol | 2022 | 35844616 | PubTator, text mining | PubMed |
| Tertiary Lymphatic Structures in Primary Hepatic Carcinoma: Controversy Cannot Overshadow Hope. | Front Immunol | 2022 | 35844587 | PubTator, text mining | PubMed |
| Key Factors for Thymic Function and Development. | Front Immunol | 2022 | 35844535 | PubTator, text mining | PubMed |
| Differentiation of Pluripotent Stem Cells Into Thymic Epithelial Cells and Generation of Thymic Organoids: Applications for Therapeutic Strategies Against APECED. | Front Immunol | 2022 | 35844523 | PubTator, text mining | PubMed |
| Diuretic Resistance Prediction and Risk Factor Analysis of Patients with Heart Failure During Hospitalization. | Glob Heart | 2022 | 35837353 | PubTator, text mining | PubMed |
| Sensory Nerves Impede the Formation of Tertiary Lymphoid Structures and Development of Protective Antimelanoma Immune Responses. | Cancer Immunol Res | 2022 | 35834791 | PubTator, text mining | PubMed |
| Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis. | Front Immunol | 2022 | 35833122 | PubTator, text mining | PubMed |
| NF-κB Inducing Kinase Regulates Intestinal Immunity and Homeostasis. | Front Immunol | 2022 | 35833111 | PubTator, text mining | PubMed |
| LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade. | J Immunol | 2022 | 35817517 | PubTator, text mining | PubMed |
| Progress and Prospects of Non-Canonical NF-κB Signaling Pathway in the Regulation of Liver Diseases. | Molecules | 2022 | 35807520 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4055/papers?page=26